Diabetes

HbA1c, waist-to-height ratio predict dyslipidemia in T1DM

(HealthDay)—For youth with type 1 diabetes, hemoglobin A1c (A1C) and waist-to-height ratio (WHtR) are modifiable risk factors that predict change in dyslipidemia, according to a study published online Jan. 26 in Diabetes ...

Diabetes

Exenatide, pioglitazone effective for poorly controlled T2DM

(HealthDay)—For patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study ...

Diabetes

Ranolazine added to glimepiride cuts HbA1c in T2DM

(HealthDay)—For patients with type 2 diabetes on background glimepiride therapy, but not metformin, addition of ranolazine is associated with a significant reduction in hemoglobin A1c (HbA1c), according to research published ...

Diabetes

Trends in insulin use, glycemic control explored

(HealthDay)—Since 1988, the proportion of patients with diabetes currently on any insulin has remained stable, according to research published online Dec. 30 in Diabetes Care.

page 8 from 16